Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Parkinson's Disease

  Free Subscription


17.08.2026

1 Exp Neurol
1 Lancet Neurol
6 Mov Disord
3 Neurobiol Dis
1 Neurochem Res
1 PLoS One
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Exp Neurol

  1. WU S, Wang W, Yang L, Pan S, et al
    Astrocytes in Parkinson's disease: Beyond support, toward therapy.
    Exp Neurol. 2026;406:115964.
    PubMed         Abstract available


    Lancet Neurol

  2. FARRER MJ
    A unified evolutionary explanation of Parkinson's disease.
    Lancet Neurol. 2026;25:802-803.
    PubMed        


    Mov Disord

  3. MANI R
    Parkinson's Disease in Wartime: From Editorial to Emergency.
    Mov Disord. 2026 Aug 13. doi: 10.1002/mds.70488.
    PubMed        

  4. CHEN KS, Kuo YJ, Jeng CY, Dong YS, et al
    Subthalamic Nucleus Deep Brain Stimulation Enhanced Long-Latency Reflex II in Parkinson's Disease Through Rapid Subthalamic-Cortical Modulation.
    Mov Disord. 2026 Aug 13. doi: 10.1002/mds.70508.
    PubMed         Abstract available

  5. QUATTRONE A, Vescio B, Arcuri F, Chiarella G, et al
    Joint Risk Factor Combinations with Additive Interaction Increase the Risk of Parkinson's Disease.
    Mov Disord. 2026 Aug 12. doi: 10.1002/mds.70462.
    PubMed         Abstract available

  6. LIN Z, Li D
    Reply to: "Dual Anatomical Targeting or Dual-Target Stimulation in Tremor-Dominant Parkinson's Disease?".
    Mov Disord. 2026 Aug 9. doi: 10.1002/mds.70466.
    PubMed        

  7. MACEROLLO A, Farah JO
    Dual Anatomical Targeting or Dual-Target Stimulation in Tremor-Dominant Parkinson's Disease?
    Mov Disord. 2026 Aug 9. doi: 10.1002/mds.70467.
    PubMed        

  8. AWOGBINDIN I, Bourque M, Morissette M, Hamelin ME, et al
    COVID-19 Amplifies Sex-Specific Dopamine and Glial Responses in a Parkinson's Disease Mouse Model.
    Mov Disord. 2026 Aug 9. doi: 10.1002/mds.70454.
    PubMed         Abstract available


    Neurobiol Dis

  9. LAURSEN AS, Willen K, Fenyi A, Volbracht C, et al
    Multiple system atrophy-derived alpha-synuclein fibrils are more potent and display oligodendrocyte cell tropism compared to Parkinson's disease-derived fibrils.
    Neurobiol Dis. 2026 Aug 14:107575. doi: 10.1016/j.nbd.2026.107575.
    PubMed         Abstract available

  10. ZHUANG Y, Zhao B, Xie H, Zhang Q, et al
    Gait-cycle-locked cortico-subthalamic signatures underlying freezing of gait and their modulation in Parkinson's disease.
    Neurobiol Dis. 2026;228:107571.
    PubMed         Abstract available

  11. POWELL M, Dzamko N
    Insulin like growth factor and cytokine signalling predict future cognitive impairment in Parkinson's disease.
    Neurobiol Dis. 2026;228:107570.
    PubMed         Abstract available


    Neurochem Res

  12. YU Y, Chen H, Zheng J, Liu S, et al
    PARK7/HSPB1-Mediated Neuroprotective Effects of SHED in an In vitro Parkinson's Disease Model.
    Neurochem Res. 2026;51:240.
    PubMed         Abstract available


    PLoS One

  13. SILCOCK C, Lupe M, Makasini S, Hale L, et al
    Experiences of Pacific Peoples and their 'aiga/kainga/kaiga/vuvale living with Parkinsons: A qualitative study.
    PLoS One. 2026;21:e0355989.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  14. LIN YE, Jaimon E, Kim Y, Loftman A, et al
    Selective loss of primary cilia and neurotrophic signaling in G51D alpha-synuclein mice highlights a common pathway to Parkinson's disease.
    Proc Natl Acad Sci U S A. 2026;123:e2619797123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum